Compare CE & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CE | TFX |
|---|---|---|
| Founded | 1918 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.8B |
| IPO Year | 2004 | 1994 |
| Metric | CE | TFX |
|---|---|---|
| Price | $44.82 | $134.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 8 |
| Target Price | $64.29 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.6M | 390.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | 0.18% | ★ 1.02% |
| EPS Growth | ★ 23.62 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $9,544,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | $3.14 | $15.97 |
| Revenue Next Year | $2.83 | $5.15 |
| P/E Ratio | $113.39 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.13 | $100.18 |
| 52 Week High | $70.70 | $139.67 |
| Indicator | CE | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 55.14 |
| Support Level | $43.14 | $119.28 |
| Resistance Level | $49.32 | $136.86 |
| Average True Range (ATR) | 1.74 | 4.19 |
| MACD | 0.06 | 0.27 |
| Stochastic Oscillator | 17.76 | 66.46 |
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.